Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$3,646.5B | 7.4 | $76.4 67.9% overvalued | 36.4% | $395.8B | $101.2B | 2.6% | 25.6% | 46.5% | 270.8% | 3.0% | |
$839.6B | 7.1 | $213.2 77.1% overvalued | 17.9% | $45.0B | ($215.8M) | 32.0% | (0.5%) | 81.6% | 63.9% | 0.0% | |
$786.9B | 6.0 | $40.2 58.8% overvalued | 66.5% | $681.0B | $6,222.0M | 5.1% | 0.9% | 24.9% | 13.2% | 66.0% | |
$468.5B | 6.7 | $299.6 71.4% overvalued | 38.5% | $258.8B | $5,014.0M | 5.4% | 1.9% | 12.7% | 20.8% | 32.9% | |
$422.1B | 8.0 | $863.4 11.3% overvalued | 58.1% | $39.0B | $6,921.8M | 15.6% | 17.8% | 46.0% | 26.2% | 63.0% | |
$411.8B | 7.1 | $135.9 22.6% overvalued | 12.1% | $84.3B | $16.7B | 0.5% | 19.8% | 51.3% | 19.2% | 67.4% | |
$401.3B | 5.8 | $197.3 18.0% undervalued | 7.2% | $88.8B | $18.1B | 4.3% | 20.3% | 69.1% | 11.6% | 51.2% | |
$389.9B | 6.4 | $238.2 38.9% overvalued | 5.0% | $159.5B | $16.3B | 4.5% | 10.2% | 33.0% | 21.2% | 207.9% | |
$372.5B | 6.0 | $336.1 58.9% undervalued | 23.8% | $56.3B | $17.8B | 3.7% | 31.7% | 73.6% | 8.3% | 1,996.0% | |
$331.6B | 6.4 | $269.1 4.1% overvalued | 48.4% | €34.2B | €4,421.0M | 9.5% | 12.9% | 73.1% | 10.1% | 25.0% | |
$320.9B | 7.4 | $89.2 67.3% overvalued | 68.8% | $81.4B | $9,982.0M | 3.6% | 12.3% | 55.1% | 7.8% | 184.6% | |
$309.3B | 5.9 | $44.5 38.5% overvalued | 24.6% | $47.1B | $4,741.0M | 2.9% | 10.1% | 61.1% | 19.4% | 168.8% | |
$278.9B | 6.3 | $113.7 25.7% overvalued | 6.1% | $197.3B | $11.0B | 0.2% | 5.6% | 48.6% | 61.4% | 16.1% | |
$256.2B | 6.1 | $77.3 21.8% undervalued | 33.3% | $54.2B | $13.2B | (5.3%) | 24.4% | 64.8% | 13.0% | 68.2% | |
$244.8B | 7.1 | $170.7 7.5% undervalued | 84.6% | $37.8B | $10.8B | 7.5% | 28.5% | 64.2% | 21.7% | (463.0%) | |
$242.4B | 7.0 | $174.5 24.5% undervalued | 19.2% | $42.0B | $6,351.0M | 4.6% | 15.1% | 55.6% | 25.3% | 31.4% | |
$236.6B | 6.2 | $205.6 17.8% overvalued | 33.1% | $62.8B | $12.2B | 1.4% | 19.5% | 56.3% | 10.3% | 213.2% | |
$224.4B | 5.9 | $65.2 67.7% overvalued | 58.3% | $45.8B | $3,678.0M | (23.7%) | 8.0% | 34.1% | 8.2% | 98.5% | |
$223.9B | 6.5 | $277.7 39.9% overvalued | 2.7% | $33.0B | $4,926.0M | (11.5%) | 14.9% | 42.2% | 9.8% | 54.8% | |
$220.0B | 6.7 | $136.4 23.3% undervalued | 12.0% | $51.1B | $13.8B | 0.1% | 27.0% | 74.7% | 17.7% | 70.8% |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover top companies with low debt to equity ratios, highlighting those with strong financial stability and reduced bankruptcy risk.
Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.